Kieble, Marita
Referentin für Pharmakoepidemiologie, Deutsches Arzneiprüfungsinstitut e. V. (DAPI), Berlin
Publikationen
- Fixkombinationen von Antihypertensiva auf dem deutschen Markt - Inklusive verfügbare Wirkstärken - Stand 15.03.2025
- Trends in Use of Antipsychotics in Germany 2014–2023: A Nationwide Population-Based Study (Posterpräsentation GAA)
- Trends in Use of Antipsychotics in Germany 2014–2023: A Nationwide Population-Based Study (Posterpräsentation ISPE)
- Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023: a nationwide population-based study
- Declining rates of fixed-dose combination pills for hypertension in Germany from 2016 to 2023
- Increased Demand for Pharmaceutical Drugs Containing Potassium Iodide In Connection with the Russia-Ukraine Conflict
- Auszeichnung als Top Downloaded Article 2021-2022
- Auszeichnung als Top Cited Article 2021-2022
- Assessment of the Prescriptions of Systemic Antibiotics in Primary Dental Care in Germany from 2017 to 2021: A Longitudinal Drug Utilization Study
- Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021
- Use of fixed‑dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia
- Verordnungsqualität oraler Fluorchinolone in den deutschen Bundesländern 2014 bis 2019
- Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave
- Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave
- Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014–2019
- Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
- “Dear Doctor” Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription
- Changes in utilization of antihypertensive drugs following angiotensin receptor blocker product recalls in Germany
- Impact On Antihypertensive Prescribing After The Dear Healthcare Professional Letter On Increased Risk Of Skin Cancer Related To Hydrochlorothiazide
- Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016
- Oral Antibiotics in Germany and the Netherlands in Primary Care from 2012 – 2016: A Comparison
- Temporal synchrony between drug dispensings and adverse drug events? The example of statins & rhabdomyolysis and metamizole or clozapine & agranulocytosis
- In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.
- Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study
- Innovative Hepatitis-C-Arzneimittel - Was der Zusatznutzen wirklich kostet
- DAPI-Zahlen aus Berlin. Die 10 häufigsten Wirkstoffe mit pharmazeutischen Bedenken
- DAPI-Zahlen aus Rheinland-Pfalz. Die 10 häufigsten Wirkstoffe mit pharmazeutischen Bedenken